<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 47 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page46.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=47">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 47 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 47</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=47"><img src="../thumb/47.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>16 / 2020-04                                                        Central Nervous System - 1.4.4
   back pain, diffic.breath., sinusit., bronchit., cough., pharyngit., rhinit.,   (S5) DISPERS.TABS 20T & 40T, 32/1.2/0103, 0104  Special precautions: Elderly partic.if receiv. multi.ther/pres.of sys-
   GI disords., hepat.enzym.elev., hepatit.somet.assoc. with jaund. &./   894243-001: 20 mg, 30, R107,50  tem.illn., epilep., discont.if seiz./rash develop., signific.liv.dysfunct.,
   liv.fail., excess.sweat., skin/ photosens. reacts., alopec., myalg., myas-  894249-002: 40 mg, 30, R215,17  mild to mod.ren.fail., underweight pts., diabet., poss adjustm to in-
   then., myopathy, urin.retent., UTI, sex. dysfunct., dysmenorrh., menstr.  Dosage: Indiv.dosage. Dissolv.dispers.tabs.in a small amount of wa-  sul.&/oral hypoglycaem.dos., ac. card.dis., grad.withdr.
   disord., vaginit., hyperprolactinaem./ galactorrh., asthen., fev., periph.   ter/swallow whole with water. Dos.above 80 mg/day not recomm.  Drug interactions: Excess.sedat.with other CNS depress., incr.&
   oed., may alt.glycaem.contr.in diab., poss. mydrias., hyponatraem.esp.  for any of the indicat.  decr. Li lev., &gt; 2-fold incr.in prev. stable plasma lev.of other anti-
   in elderly, CNS/GI disturbs. on treatm.discont.  Depress: 20 mg/day.  depress., adverse effs. with tryptophan, bear in mind long elimi-
   Special precautions: Worsen.depress./emerg. suic.ideat./-behav   Bulimia: 60 mg/day   nat. half-life of fluoxetine & it’s metabolites, half-life of diazepam
   risk in maj.depress./psych. disords., monit.pts.esp.dur.early ther.&   Obsess.compuls.disords: 20-60 mg/day.  poss. prolong., alter.plasma conc.of other plasma prot. bound drugs.
   dos.chang. for clinic.worsen./suic.ideat., monit.other psych.& non-  Contraindications: Within 14 days of an MAOI/ admin of an MAOI
   psych. disord.pts., consid.chang.ther.regim./ discont. if psych.sympt.  within 5 wks of discont. fluoxetine, sev.ren.fail., safety in porphyr./  RECITA, Aurobindo [P/S]
   occur which are sev./ abrupt in onset/not part of pres.sympt., dos.  pregn./ childr. & lactat.not est., risk of serot.syndr.with use of fluox-  Citalopram hydrobromide
   taper. if discont., avoid in poor.contr.epilep., mania hist., poss. NMS   etine alone/ combin.MAOI,SSRI,serot. agents discont.use.  Indications: Depress.& relapse prev., panic disord. with/without
   with concom.neurolept., concom. meds. incr.bleed.risk/known bleed.  Side effects: Asthen., fev., palpitat., vis. disturbs., GI disords.,   agoraphob., obsess.-compuls. disord.
   tenden./ predispos. condits., concom.alcoh.not advis., concom. di-  CNS effs., dyspn., skin & anaphalactoid reacts., sex.dysfunct., hy-  (S5) TABS, 41/1.2/0531
   goxin, monit.Li lev., concom.phenytoin, reduc. procyclidine dos.in   pothyroid., hyponatraem., aplast.anaem., CVA, confus., dyskines.,   713356-001: 20 mg, 30, R77,37
   case of anticholinerg. effs., concom.oral anticoags./aspir./NSAID/   ecchymos., eosinophil.pneum., GI haemorrh., hyperprolactinaem.,   Dosage: Admin.morn.or even. Onset of act.2-4 wks. Contin.treatm.
   sumatriptan, monit.concom.theophyll.ser.conc., hostility/ suic.ideat./  movem.disords., neurolept. malign.syndr.-like events, pancreatit.,   up to 6 mnths.aft.recov.to prev. relapse.
   self-harm report.in childr., sev. ren./hepat.impairm., elderly, avoid   bld. dyscras., suic.ideation, vag.bleed.aft.withdr., weight loss, incr.  Depress: 20 mg as sngl.dly.dos. May be incr.by 20 mg/day at interv.
   abrupt discont., discont.if prolong.elev.of liv.funct.test results, diab.  transamin.lev., arthralg., myalg.  of at least 1 wk.to max.40 mg depend.on respons.
   mellit., little clinic.exper.with ECT, discont. if seiz.devel./incr.freq.,   Special precautions: Elderly, epilep., discont.if seiz./ rash develop.,   Panic disord: 10 mg as sngl.dos.for first wk then incr.to 20 mg/day.
   narr.angle glauc., admin. in ser.CV disords.not studied theref.avoid.,   ren./liv.impairm., ac.card.dis., underweight pts., diabet., poss adjustm   May be incr.to max.40 mg/day depend.on respons.
   withdr. sympt.with abrupt discont., dos.at low. range with concom.  to insul. &/ oral hypoglycaem.dos., monit.other psych./non-psych.   Obsessive-compuls.disord: 20 mg/day as sngl. dos. May be incr.
   known drug metabolis.enzyme inhibit.  disord.pts., bleed./extrapyrimid.disord.hist.  by 20 mg increm.to max.40 mg/ day depend. on respons.
   Drug interactions: Elev.thioridazine plasma lev. lead. to QTc-interv.  Drug interactions: Excess.sedat.with other CNS depress., TCA’S   Elderly: 10-20 mg/day as sngl.dos. May be incr.to max. 20 mg/day
   prolongat., toxic.of risperidone poss.incr., poss.incr.bioavail.with cime-  bld.lev.incr., &gt; 2-fold incr.in prev. stable plasma lev.of other antide-  depend.on respons.
   tidine, decr. bioavail.with phenytoin, poss.seroton.syndr.with MAOI/  press., incr.& decr. Li lev., serotonerg.effs.enhanc.with tryptophan / Li,   Contraindications: Concom.MAOI/other drugs affect.serotonerg.
   tryptophan, incr.adverse effs.with anti-convuls. & sumatriptan, incr.  half-life of diazepam poss. prolong., alter.plasma conc.of other plasma   neuro transmit.systs./ sev.ren. impairm.(creat.clear.&lt; 20 ml/ min.),
   syst.avail.of pimozide, incr. procyclidine plasma lev.& other anti-cho-  prot. bound drugs, reduc.dos.of drugs metabol.by cytochrome P450   safety & effic. in pregn.& lactat./ childr.und.18 yrs.not est., con-
   linergs., poss.incr.bleed.in pres.of unalt. prothrob. times with warfar.,   CYP2D6 as enzyme inhibit.  genit.long QT syndr./prod.that prolong QT interv., concom.pimozide
   elev.theophyll.conc., P450 isozyme CYP2D6 respons.for metabol.of   Side effects: Freq: Sleep disturbs., somnol., naus., dry mouth,
   debrisoquine & sparteine inhibit.enhanc.plasma lev. of concom.meds.  PROLAX, (Unicorn) Dezzo Trading [P/S]  sex.dysfunct.incl.ejaculat.disord., decr.libido, anorgasm. Less.freq:
   metabol.by this isoenzyme, syst. avail.reduc.by primidone/phenobarb.  Fluoxetine HCl equiv.to fluoxetine.  weight changes, paraesthes., agitat., fat., man., seroton.syndr.,
                                Indications: Maj.depress.episod., obsess. compuls. disord., bu-  bradycard., trem., QT prolongat., torsades de pointes, diarrh., dys-
   PAXIL, GSK [P/S]             lim.nervosa.                  peps., salivat., sweat., rash, asthen., micturit.disords., yawn., hos-
   Paroxetine                   (S5) CAPS. A38/1.2/0413       tility, suicid. ideat., self harm in childr. Unknown freq: Anaphylax.,
   Indications: Sngl.episod.& recurr.maj.depress. with assoc.anx.  719658-001: 20 mg, 28, R29,11  angioed., restlessn., headache, dizzin., confus., imp.conc., malaise,
   esp.where sedat.not requir., low. dos. treatm. for up to 1 yr.to prev.  Dosage: Consid.less freq./low.dos.with concurr. illness/ hepat.  convuls., NMS, accomodat. disturbs., mydrias., palpitat., nas. con-
   relapse & recurr. of furth.depress.episod., panic disord.with/without   impairm. Upward dos.titr.advis.at interv. of sev.wks. Dly.dos.above   gest., constip., hepatit.
   agoraphobia, short term treatm.of sev.disabl. obsess. compuls.dis-  80 mg not recomm. Elderly: Dos.above 20 mg/day not recomm.  Warnings and special precautions: Elderly, hepat./ren.impairm.,
   ord., social phobia., generalis. anx. disord.  Adults:     seiz./hist.therof, epilep., poor.contr.epilep.electroconvuls.ther., ma-
   (S5) TABS, A39/1.2/0078      Maj.depress: 20 mg dly pref.in morn.  nia/ hist.therof, discont.if pt.enters manic phase, pre-exist.slow
   704794-001: 20 mg, 28, R249,30  Obsess.-compuls.disord: 20-60 mg dly.  heart rate, diab.mellit., monit.pts.esp. dur.early ther.& dos.chang.for
   Dosage: Admin.once dly.in the morn.with food. Swallow whole.  Bulim.nervosa: 60 mg dly.  clinic. worsen./ suicid. ideat./behav., monit.other psych.& non-psych.
   Depress: Recom.dos: 20 mg dly. If necess.may be incr.grad.in 10 mg   Contraindications: Concom. MAOI, sev.ren. funct. impairm., safety   disord.pts., consid.chang.therap.regim./ discont. if psych.sympts.oc-
   increm.to max. 50 mg/day accord. to pt.response.  & effic.in childr.not est.  cur which are sev./ abrupt in onset/not part of pres.sympts., withdr.
   Panic disord: Recomm.dos: 40 mg dly. Init. 10 mg /day incr.wkly   Side effects: Freq: CNS effs., headache, drowsin., insomn., trem.,   grad., correct hypokalaem.& hypomagnesaem.bef. init. & monit.peri-
   in 10 mg increm.accord.to respons. Max.60 mg/day. Low init.start.  asthen., GI disturbs., decr. libido, sex.dysfunct., rais.transamin.lev.,   odic., ECG monit.recomm.in CHF/ bradydysarrhythm.& with concom.
   dos.is recomm.               skin/ anaphylactoid reacts., excess.sweat., ser. sickn. Less freq:   meds.prolong QT interv., dos.incr.over 20 mg/day in CYP2C19 poor
   OCD: Recomm.dos: 40 mg dly. Init.20 mg/day incr. weekly.in 10 mg   Palpitat., dizzin., abnorm. dreams, agitat., seiz., hypoman., mania, dys-  metabolis./ with concom.cimetidine/another CYP2C19 inhibit.not
   increm.accord.to respons. Max. 60 mg/day.  kines., weight loss, hyponatraem., hypothyroid., fev., dyspeps., vomit.,   recomm., serotonin syndr. more likely aft.dos.incr., lact.intol., consid.
   Social phobia: Recomm.dos: 20 mg dly. Incr. dos. in 10 mg increm.  dry mouth, arthralg., myalg., vis. disturbs., dyspn., pulm.inflamm.&/  potent. S/E bef. driv./operat. machinery, excret.in breast milk, infts.
   as requir. Max.dly.dos: 40 mg accord.to response  fibros., aplast. anaem., CVA, confus., ecchymos., eosinophil. pneum.,   expos.in late pregn.have develop. complicat.requir.prolong.hospitali-
   Gen.anx.disord: Recomm.dos. 20 mg dly. If unrespons.incr.dos.as   GI haemorrh., hyperprolactinaem., NMS-like events, pancreatit.,   sat.& incr.risk of persist.pulm.hypertens.
   reqd.to max.50 mg/day        suicid.ideat., bld.dyscras., vag. bleed.aft.ther.withdr., violent behav.  Interactions: Ser./potent.fatal reacts.with MAOI, incr.conc.of imi-
   Contra-indications: MAOI, safety & effic.in childr. und.18 yrs.not   Warnings: Discont.ther.if seroton.syndr.occurs/ rash develop./other   pramine’s active metabol. desimipramine, incr.risk of serotonin syndr.
   est., pregn., safety in lactat. not est., concom.thioridazine/tryptophan/  allerg.reacts., anaphylact./ser. syst. events involv.skin/kidn./lung/liv.  with other serotonerg.meds/meds with serotonerg. activ., serotonin
   pimozide, concom.seroton.precurs. (eg. L-tryptophan, oxitriptan) incr.  report., monit. pts.with maj.depress.disord., both adults & childr. esp.  syndr.report.with concom. moclobemide overdos., effs.of alcoh.incr.,
   serotonerg.syndr.risk.       dur.early ther./dos.chang.for clinic. worsen. & suicid./behav., monit.  anticoag. activ.of warfar.incr., AUC & max.plasma conc. incr.with ci-
   Side-effects: Abnorm.bleed. predomin.of skin & mucous membr.  other psych.& non-psych. disord.pts., consid.chang.therapeut. regim./   metidine, ECG monit.recomm.with concom. meds.prolong QT interv.,
   (mostly ecchymos.also GI tract/ CNS & eye). allerg.reacts. SIADH, decr   discont.if psych.sympt.occur which are sev./ abrupt in onset/not part   mean incr.in QTc values with pimozide
   appetite., hyponatraem.esp.in elderly, psych.disord., manic reacts.,   of pres.sympt., discont. grad., avoid concom.alcoh.
   CNS effs., extrapyramid.sympts., convuls., seroton.syndr., blurr.vis.,   Special precautions: Safety & effic.in pregn.& lactat. not est., seiz.  SERDEP 50, 100, Cipla Medpro [P/S]
   ac glauc., yawn., GI disords., dry mouth, elev.hepat.enyme., hepatit.   hist., discont.if seiz.develop.& avoid in unstab.epilep., monit.contr.epi-  Sertraline HCl.
   poss. assoc.with jaund./liv.fail., sweat., skin rash, photosens.reacts.,   lep., ECG, hepat./ ren.funct. impairm., underweight indiv., diab. mellit.,   Indications: Maj.depress.disords.such as sngl. episod. & recurr.
   urin.retent., sex.dysfunct., hyperprolactinaem./ galactorrh., asthen.,   bleed.disord.hist., extrapyramid. disords., aggrav.of Parkinson’s dis.,   depress., obsess.compuls.disord., panic disord.with/-out agoraphob.
   periph. oed., neurolept malign.syndr., akathis.  ac.card.dis., withdr. sympt.poss.with discont.  (S5) TABS, 38/1.2/0020, A38/12.2/0617
   Warnings and special precautions: Monit.pts. for clinic.   Interactions: Poss.seroton.syndr.with MAOIs, interacts with CNS   705420-001: 50 mg, 30, R96,90
   worsen.& suicide.through.treatm.& esp. at begin.of treatm./dos.  act.meds., potent.interact.with other meds.metabol.by cytochrome   715935-001: 100 mg, 30, R121,80
   chang., worsen.depress./ emerg. suicide ideat./-behav risk in maj.  P450 CYP2D6, incr./decr.Li-conc.theref.Li lev.monit., bld.lev. chang.   Dosage: Admin as sngl.dly.dos.
   depress./ psych. disords., consid.chang.therapeut.regim/ discont.if   with phenytoin/carbamazepine/ haloperidol/ clozapine/alpra-  Depress: Init. 50 mg dly. Usual therapeut.dos. 50 mg dly. May be titr.
   psych.sympts.occur which are sev./ abrupt in onset/not part of pres.  zolam/imipiramine/ desipiramine, diazepam half-life poss.prolong.,   up in 50 mg increm.at 2 wk. interv.to max.150-200 mg/day.
   sympts., outweigh benef.-risk in pregn.& lactat., mania hist., bipol.   cert. adverse effs.with tryptophan, alter.plasma conc. of other prot.  OCD: .Min.effect.dos. 50 mg dly. Incr.above 100 mg dly have no addit.
   disord.risk screen.recomm.prior to init.treatm., concom. neurolept./  bound meds.such as warfar./ digoxin, coagul.monit.with warfar./  benef. Eff.observ.within 1 wk.& full activ.aft. 2-4 wks.
   serotonerg.meds., concom.oral anticoags., concom.alcoh.not advis.,   when fluoxetine discont.  Panic disord: Re-eval.usefulness.periodic. Init. 25 mg dly.incr.to 50
   elderly, sev. ren./hepat.impairm., discont.in cases of ser.liv. funct.ab-  mg dly.aft.1 wk. Min. recomm. effect.dos: 50 mg dly. This regim.re-
   normalit., avoid in extrapyramid.disords.& concurr.neurolept.meds.,   RANFLOCS, Ranbaxy [P/S]  duc.freq.of early treatm.emerg.S/E.
   withdr.sympts.with abrupt discont., Li ther., reduc.procyclidine dos.  Fluoxetine HCl  Contraindications: MAOI, safety in childr.und. 18 yrs.not est.,
   in case of anticholinerg.effs., admin.in ser.CV disords. not studied.,   Indications: Maj.depress., bulim.nervosa, obsess. compuls.disords.  ren./hepat.insuff., safety in pregn. & lactat. not est., concom.al-
   epilep., discont.in pts. develop. seiz., little clinic.exper.with ECT, nar-  (S5) CAPS. 34/1.2/0129  coh., agents enhanc. serotonerg. neurotransmiss. eg.tryptophan &
   row angle glauc., concom.meds.incr.bleed.risk/known bleed.tenden./  700686-001: 20 mg, 30, R34,22  fenfluramine not advis.
   predispos.condits., hostility/suicide ideat.& self harm report.in childr.,   Dosage: Indiv.dosage. Dos.of up to 80 mg/day admin.in div.dos.  Side effects: Seiz., hyperprolactinaem., galactorrh., incr.sweat., dry
   poss.assoc. bone fract.risk  if necess.                    mouth, thirst, sex.dysfunct., somnol., trem., dizzin., headache, paraes-
   Drug interactions: Poss.incr.bleed.in pres.of unalter. prothrob.times   Adults only.  thes., hypoaesthes., twitch., hyperton., movem.disords., yawn., taste
   with oral anticoag/warfar., metabol.& pharmacokinet.poss.aff.by in-  Depress: 20 mg/day.  pervers., psych. disords.incl.anx./agitat./psychos., vis.disturbs., tinnit.,
   duct./ inhibit.of drug metabol.enzym., poss.incr.bioavail. with cimeti-  Bulimia: 60 mg/day.  palpitat., rhinit., pharyngit., GI disturbs., incr.appet., pancreatit., ser.
   dine, decr.bioaval.with phenytoin, poss.seroton.syndr.with serotonerg.  Obsess.compuls.disords: 20-60 mg/day.  liv.events, skin reacts. incl.erythem.multiform., myalg., micturit.freq/
   meds. & tryptophan, incr.incid.of adverse effs.with anti-convuls., incr.  Contra-indications: Sev.ren.fail., within 14 days of an MAOI/ad-  disords., menstr.sympts., fatig., hot flush., fev., back pain, extrapyra-
   procyclidine plasma lev.& other anti-cholinergs, incr.plasma conc.of   min of an MAOI within 5 wks of discont. fluoxetine, safety in pregn./   mid.sympts., Parkinson’s aggrav., elev.AST/ALT lev., hyponatraem.,
   co-admin.meds. metabol.by DYP2D6, toxic of risperidone poss.incr,   childr.& lactat.not est.  alt. platelet funct., abnorm.bleed./purpura, CNS effs., withdr.sympt.
   elev.thioridazine plasma lev.lead.to QTc-interv. prolongat.  Side-effects: Rash, allerg.reacts., asthen., fev., palpitat., vis.dis-  with sudd.discont.
                                turbs., GI disords., CNS effs., mania, convuls., extrapyramid.effs., sex.
                                                              Special precautions: Use for more than 12 wks. not eval.in panic
   PROHEXAL 20, Sandoz [P/S]    dysfunct., dyspn., pulm.events, skin & anaphylactoid reacts., hypothy-  disord., poss.activat.of mania/ hypoman., poss.signific.weight loss,
   Fluoxetine HCl               roid., hyponatraem., aplast.anaem., CVA, confus., dyskines., ecchy-  avoid in unstable epilep, monit.control.epilept., discont. ther.if seiz.
   Indications: Maj.depress., bulim.nervosa, obsess. compuls.disords.  mos., eosinophil.pneum., GI haemorrh., hyperprolactinaem., movem.   develop., uric acid ser.lev.decr., risks/ benefits of concom.ECT ther.not
   (S5) CAPS. 31/1.2/0638.      disords., neurolept. malign.syndr.-like events, pancreatit., bld. dys-  est., dis./condits. affect. metabol./haemodynam.respons., not eval.
   879282-010: 20 mg, 30, R56,84  cras., suic.ideation, vag.bleed.aft.withdr., violent behav., weight loss.  /used with MI/unstab.heart dis., liv.dis., ren. impairm., close super-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page46.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page42.html">42</a>&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>&nbsp;&nbsp;&nbsp;<a href="page48.html">48</a>&nbsp;&nbsp;&nbsp;<a href="page49.html">49</a>&nbsp;&nbsp;&nbsp;<a href="page50.html">50</a>&nbsp;&nbsp;&nbsp;<a href="page51.html">51</a>&nbsp;&nbsp;&nbsp;<a href="page52.html">52</a>
             </td>
             <td width="35%"><a href="page48.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page48.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
